iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 4,060.00
-20.00 (-0.49%)
Apr 1, 2026, 3:30 PM KST
iNtRON Biotechnology Company Description
iNtRON Biotechnology, Inc. engages in the development of novel biopharmaceutical drugs in South Korea.
It develops bacteriophage and endolysin based drugs through itLysin and IMPA platform. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
iNtRON Biotechnology, Inc.
| Country | South Korea |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 73 |
Contact Details
Address: Thespia 5th floor, 701-704 Seongnam-si South Korea | |
| Phone | 82 3 1739 5678 |
| Website | intron.co.kr |
Stock Details
| Ticker Symbol | 048530 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7048530000 |
| SIC Code | 2836 |